NDC properties for "benzocaine 14 % / butamben 2 % / tetracaine 2 % Topical Gel" (RxCUI 308645)
About this data
The tables show NDC propoerties for benzocaine 14 % / butamben 2 % / tetracaine 2 % Topical Gel with the RxCUI 308645
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for benzocaine 14 % / butamben 2 % / tetracaine 2 % Topical Gel (RxCUI 308645)
| MMSL_CODE | CD4038 |
|---|---|
| RxCUI | 308645 |
| VUID | 4007847 |
| Prescribable Synonym | benzocaine 14 % / butamben 2 % / tetracaine 2 % Topical Gel |
| RXNAV_STR | benzocaine 0.14 MG/MG / butamben 0.02 MG/MG / tetracaine 0.02 MG/MG Topical Gel |
| RxNorm Name | benzocaine 0.14 MG/MG / butamben 0.02 MG/MG / tetracaine 0.02 MG/MG Topical Gel |
| RxNorm Synonym | benzocaine 14 % / butamben 2 % / tetracaine 2 % Topical Gel |
| Related queries | Interactions (for RxCUI 308645) |
NDC Properties
no results for this query in NIH